Survey: Lived experience & Quality of life
Call for participants – “Exploring the lived experiences and quality of life of individuals affected by CAH”
If you’re 18 years and over and living with CAH, tell us how CAH affects your life in an individual discussion held at a convenient time face-to-face or online.
The aim of this study is to find out how CAH affects the quality of life of people affected by this condition. We will be carrying out interviews with people affected by CAH to find out how having this condition affects people’s daily lives and well-being at different stages in their life. The study findings will be used to help us develop a quality of life questionnaire that focuses on the unique issues affecting people with CAH. The questionnaire could eventually be used by health professionals and researchers to improve the care of individuals with the condition.
Individuals over the age of 18 with a diagnosis of CAH are eligible to take part in this study. Partners or relatives of people with CAH are also welcome to participate. The study will involve a one-to-one online or face-to-face interview at a convenient date and time. We expect the interviews to last about an hour. A £20 Amazon voucher will be provided to people who take part as reimbursement for their time.
The research is being led by Professor Aled Rees, Professor of Endocrinology and Consultant Endocrinologist Cardiff University, in collaboration with Cardiff Metropolitan University and Living with CAH. The study has been approved by the Cardiff University School of Medicine Research Ethics Committee: 24/32.
If you are interested in taking part in the study, download the flier here.
Recent Blog Posts
Article: Adult Quality of Life with CAH
A new study published in Endocrine Connections explores the lived experiences of adults with congenital adrenal hyperplasia (CAH) and the wide-ranging impact the condition can have on quality of life. Through in-depth interviews with adults living with CAH as well as...
Liquid Hydrocortisone Discontinued in the UK
Liquid hydrocortisone injections have been discontinued in the UK, affecting emergency treatment for people with adrenal insufficiency. This follows the supply shortage reported in February 2025 -...
Medicine security – a national UK priority.
Concerns about medicines shortages in the UK have been highlighted in recent analysis from the House of Lords Public Services Committee and the Royal Pharmaceutical Society. The House of Lords Public Services Committee warns that medicines supply should be treated as...